Skip to content
Catalyst

PapersPMID:30036516

Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.

The Journal of urology2018The record ↗

  1. Finding, moderate evidenceno difference foundUrinary calcium excretion

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • “H3Cit did not significantly alter citraturia, calciuria, pH, or ammonium compared with placebo (and Table 2).”
    Study
    crossover
    Duration
    7 days
    Dose studied
    citric acid (H3Cit) tablets, 30 mEq twice daily (60 mEq per day) with breakfast and dinner, versus matching placebo
    Population
    13 recurrent calcium phosphate stone formers without hypercalciuria, on a fixed metabolic diet in all phases

Study record

Design
crossover trial
Species
human
Population
recurrent calcium phosphate stone formers without hypercalciuria
Participants
13
Comparator
placebo
Duration
7 days
Endpoints measured
20